Atlas Trials

2015-09: a Phase II Randomized, Open-label Study of Anti-signaling Lymphocytic Activation Molecule Monoclonal Antibody During Maintenance Therapy

Clinical trial NCT03000634 · WITHDRAWN

Trial details

NCT number
NCT03000634
Sponsor
University of Arkansas
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2017-04-01
Primary completion
2017-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.